TAZ anticorps (AA 46-239)

N° du produit ABIN7439171

Détail du produit anti-TAZ anticorps

Antigène: TAZ (Tafazzin (TAZ))

Épitope: AA 46-239

Reactivité: Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TAZ est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Fonction: Polyclonal Antibody to Tafazzin (TAZ)

Specificité: The antibody is a rabbit polyclonal antibody raised against TAZ. It has been selected for its ability to recognize TAZ in immunohistochemical staining and western blotting.

Purification: Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Immunogène: Recombinant Tafazzin (TAZ) corresdonding to Asn46~Phe239 with N-terminal His Tag

Isotype: IgG

Information d'application

Indications d'application:

Western blotting: 0.5-2 μg/mL Immunohistochemistry: 5-20 μg/mL Immunocytochemistry: 5-20 μg/mL Optimal working dilutions must be determined by end user.

Commentaires:

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Date de péremption: 24 months

Détails sur TAZ

Antigène: TAZ (Tafazzin (TAZ))

Autre désignation: Tafazzin (TAZ Produits)

Synonymes: anticorps wu:fb39f12, anticorps zgc:91803, anticorps MGC54019, anticorps TAZ, anticorps taz, anticorps GB11956, anticorps Afu2g13960, anticorps BTHS, anticorps CMD3A, anticorps EFE, anticorps EFE2, anticorps G4.5, anticorps LVNCX, anticorps Taz1, anticorps 5031411C02Rik, anticorps 9130012G04Rik, anticorps AW107266, anticorps AW552613, anticorps tafazzin, anticorps tafazzin L homeolog, anticorps tafazzin homolog, anticorps TAZ, anticorps taz, anticorps taz.L, anticorps LOC550948, anticorps AFUA_2G13960, anticorps AOR_1_318014, anticorps Tsp_06712, anticorps Taz

Sujet: CMD3A, EFE2, EFE, BTHS, XAP-2, G4.5, Barth syndrome, Endocardial Fibroelastosis 2, Cardiomyopathy,Dilated 3A(X-Linked)